Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 498-504, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sjöroos, M.
Right arrow Articles by Lövgren, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sjöroos, M.
Right arrow Articles by Lövgren, T.
Related Collections
Right arrow Clinical Immunology
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2001;47:498-504.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Solid-Phase PCR with Hybridization and Time-resolved Fluorometry for Detection of HLA-B27

Minna Sjöroos1,2,a, Jorma Ilonen1,2 and Timo Lövgren3

1 JDF Center for Prevention of Type 1 Diabetes in Finland, and Departments of
2 Virology and
3 Biotechnology, University of Turku, Turku, Finland.
a Address correspondence to this author at: MediCity Research Laboratories, Tykistökatu 6 A, 4th floor, FIN-20520 Turku, Finland. Fax 358-2-333-7000; e-mail minna.sjoroos{at}utu.fi.

Background: Preactivated solid surfaces provide new possibilities for multiple consecutive reactions in a microtiter plate format. In this study, a combination of PCR and subsequent hybridization in the same microtiter well was applied for the detection of HLA-B27 alleles.

Methods: A multiplex solid-phase PCR to amplify the HLA-B27 alleles together with ß-actin as an amplification control gene was performed on the NucleoLinkTM (Nunc) surface. PCR was followed by hybridization and detection with time-resolved fluorescence. For the covalent capture of the PCR primers onto the solid support via a 1-(3-dimethylamino-propyl)-3-ethylcarbodiimide hydrochloride-mediated reaction, different 5'-end modifications of oligonucleotides were tested [amination, phosphorylation, and a poly(dT)10 linker].

Results: For covalent immobilization of the primers, amination of the 5' end combined with use of the poly(dT)10 linker was superior. At least 19.5% of the primer added per well was attached via a stable bond. When the standard time-resolved, fluorescence-based HLA-B27 detection system was compared with the newly developed method in a sample series of 82 genomic DNAs and the corresponding dried-blood spots, all results were in full agreement.

Conclusions: The new solid-phase PCR approach can be applied for multiple-target DNA detection. PCR followed by hybridization can be accomplished in a few hours using precoated strips and dried-blood spot PCR templates.




The following articles in journals at HighWire Press have cited this article:


Home page
Nucleic Acids ResHome page
A. Pemov, H. Modi, D. P. Chandler, and S. Bavykin
DNA analysis with multiplex microarray-enhanced PCR
Nucleic Acids Res., January 20, 2005; 33(2): e11 - e11.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. S. Turner, S. Penning, A. Sharp, V. J. Hyland, R. Harris, C. P. Morris, and A. van Daal
Solid-Phase Amplification for Detection of C282Y and H63D Hemochromatosis (HFE) Gene Mutations
Clin. Chem., August 1, 2001; 47(8): 1384 - 1389.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.